Lupus (SLE) Blood Tests: Antibodies and Diagnosis
Content last reviewed 2026-09-12 · Educational information — not medical advice
Quick answer
Lupus diagnosis combines clinical criteria (rash, arthritis, serositis, kidney...) with antibody testing: ANA (required for diagnosis), anti-dsDNA (disease-activity linked), complement levels (low in active disease). The 2019 EULAR/ACR classification criteria formalized the scoring.
The antibody cascade
- ANA screening — positive in >95% of SLE (negative ANA essentially rules it out)
- Anti-dsDNA — SLE-specific (~95% specificity); titers FLUCTUATE with disease activity (rising = flare prediction)
- Anti-Smith — highly specific but only ~20% sensitive; marks SLE when positive
- Complement C3/C4 — CONSUMED in active disease (low = immune-complex activation)
- Antiphospholipid antibodies — present in ~30% of SLE (thrombosis risk)
Classification criteria snapshot
2019 EULAR/ACR: antinuclear antibodies (ANA ≥1:80) as entry criterion → additive scoring across clinical domains (constitutional, hematologic, neuropsychiatric, mucocutaneous, serosal, musculoskeletal, renal) plus immunologic (dsDNA, complement, APS antibodies). ≥10 points classifies SLE. This replaced outdated '4-of-11' criteria.
Complement levels as activity trackers
Low C3 and/or C4 during flares normalize with treatment — useful for monitoring lupus nephritis activity. Persistent hypocomplementemia predicts relapse risk. C3 alone less reliable than C4 for tracking. Congenital complement deficiencies (C2, C4) predispose to SLE — very low levels despite quiescent disease suggest deficiency rather than consumption.
Non-serologic testing in SLE
Urinalysis (proteinuria, cellular casts — nephritis screening), CBC (cytopenias hallmark), ESR (often elevated — correlates poorly with activity), and anti-dsDNA/ complement trending form the monitoring backbone between clinic visits.
Order this test online
Direct-access laboratory testing — no appointment or doctor visit required. Results delivered as secure PDFs.
We may earn a commission when you order through partner links. Educational content only — never a substitute for professional medical advice.
Related guides
Frequently asked questions
Can lupus be seronegative?
Very rare with modern testing — ANA-negative SLE exists but represents <2% of cases; alternative diagnoses usually surface with re-evaluation.
How often should I repeat anti-dsDNA?
Every 3-6 months in active disease; annually if stable — upward trends prompt preemptive therapy adjustments before clinical flares.